Effect of L-dopa in schizophrenia.
D000328:Adult; D000342:Affective Symptoms; D001519:Behavior; D003072:Cognition Disorders; D003142:Communication; D003702:Delusions; D003861:Depersonalization; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004644:Emotions; D005260:Female; D006212:Hallucinations; D006801:Humans; D007536:Isomerism; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D012649:Self Concept; D013850:Thinking; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014473:Unconscious, Psychology
D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine